Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Yousef Al-Shraideh; Samir V. Sejpal; Joshua J Meeks

doi:10.1016/B978-0-12-800077-9.00031-1

Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Yousef Al-Shraideh^*, Samir V. Sejpal, Joshua J Meeks

^*Corresponding author for this work

Urology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

Original language	English (US)
Title of host publication	Prostate Cancer
Subtitle of host publication	Science and Clinical Practice: Second Edition
Publisher	Elsevier Inc
Pages	275-280
Number of pages	6
ISBN (Print)	9780128000779
DOIs	https://doi.org/10.1016/B978-0-12-800077-9.00031-1
State	Published - Dec 3 2015

Keywords

PSA
Prostate cancer
Radiation treatment
Radical prostatectomy
Surgery

ASJC Scopus subject areas

Medicine(all)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/B978-0-12-800077-9.00031-1

Cite this

@inbook{a956c0b6bef046b3a99f8f45670c517b,

title = "Radiation-Resistant Prostate Cancer and Salvage Prostatectomy",

abstract = "One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.",

keywords = "PSA, Prostate cancer, Radiation treatment, Radical prostatectomy, Surgery",

author = "Yousef Al-Shraideh and Sejpal, {Samir V.} and Meeks, {Joshua J}",

year = "2015",

month = dec,

day = "3",

doi = "10.1016/B978-0-12-800077-9.00031-1",

language = "English (US)",

isbn = "9780128000779",

pages = "275--280",

booktitle = "Prostate Cancer",

publisher = "Elsevier Inc",

}

TY - CHAP

T1 - Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

AU - Al-Shraideh, Yousef

AU - Sejpal, Samir V.

AU - Meeks, Joshua J

PY - 2015/12/3

Y1 - 2015/12/3

N2 - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

AB - One in six men in the Unites States will be diagnosed with prostate cancer accounting for an incidence of 233,000 cases per year. Nearly half of the men that choose treatment will receive radiation therapy (RT), and depending on the aggressiveness of their tumor, an unknown but significant percentage will have radiation refractory cancers. Identifying recurrences post RT remains challenging with limited biomarkers that can identify persistent cancer. In this chapter, we will highlight methods to detect recurrence after RT, and discuss the oncologic and function outcomes of surgical salvage treatment.

KW - PSA

KW - Prostate cancer

KW - Radiation treatment

KW - Radical prostatectomy

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84966769133&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966769133&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800077-9.00031-1

DO - 10.1016/B978-0-12-800077-9.00031-1

M3 - Chapter

SN - 9780128000779

SP - 275

EP - 280

BT - Prostate Cancer

PB - Elsevier Inc

ER -

Radiation-Resistant Prostate Cancer and Salvage Prostatectomy

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this